The Rafael del Pino Foundation and the Foundation for Biomedical Research at the Puerta de Hierro Hospital set up the Rafael del Pino Chair in Neuroscience led by Dr. Jesús Vaquero.
The project consists in applying personalised cell therapy for the treatment of people with spinal cord injuries. The project’s results are the best published to date for recovery from chronic spinal cord injury. The research conducted by neuroscientist, Jesús Vaquero, and his team with the Foundation’s support has resulted in the design of the first human cell therapy medication –NC1–, which was approved by the Spanish Agency for Medicines and Medical Devices (AEMPS) in 2019. This drug treatment has shown that it is possible to mitigate the severe consequences of spinal cord injury, leading to improvements in the quality of life of people with these injuries.
The excellent results obtained in the six non-commercial clinical trials conducted by Dr. Vaquero mean that use of the drug can be extended to neurodegenerative diseases, traumatic brain injury, Alzheimer’s and other forms of dementia in which decreased brain metabolism plays a key role. The partners that make this project possible are: the Rafael del Pino Foundation, the Mapfre Founsation and the Regional Government of Madrid.
For more information, please contact Doctor Vaquero’s team via e-mail email@example.com